Rezolute (RZLT) Accumulated Expenses (2011 - 2026)

Rezolute's (RZLT) quarterly Accumulated Expenses came in at $1.0 million in Q1 2026, down 0.96% year-on-year from $1.0 million in Q1 2025, and down 32.51% quarter-over-quarter from $1.5 million in Q4 2025.

Rezolute (RZLT) Accumulated Expenses (2011 - 2026) Analysis & Trends

Rezolute has disclosed Accumulated Expenses across 16 years of filings, most recently posting $1.0 million for Q1 2026.

  • Accumulated Expenses for Q1 2026 came in at $1.0 million, down 0.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (down 0.96% YoY), and the FY2025 annual result was $2.3 million, up 25.22% from the prior year.
  • Accumulated Expenses came in at $1.0 million for Q1 2026 at Rezolute, down from $1.5 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $4.0 million in Q4 2024 to a low of $450000.0 in Q1 2022.
  • The 5-year median for Accumulated Expenses is $1.7 million (2023), against an average of $1.9 million.
  • Across the five-year window, Accumulated Expenses soared 150.0% in 2022 and plunged 61.5% in 2025, its largest moves.
  • Rezolute's Accumulated Expenses stood at $2.2 million in 2022, then advanced by 11.15% to $2.5 million in 2023, then soared by 60.25% to $4.0 million in 2024, then slumped by 61.5% to $1.5 million in 2025, then slumped by 32.51% to $1.0 million in 2026.
  • The last three Accumulated Expenses figures came in at $1.0 million (Q1 2026), $1.5 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Rezolute 520.13 Mn 520.13 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.03 Mn
Dec 31, 2025 1.53 Mn
Sep 30, 2025 3.32 Mn
Jun 30, 2025 2.27 Mn
Mar 31, 2025 1.04 Mn
Dec 31, 2024 3.98 Mn
Sep 30, 2024 2.65 Mn
Jun 30, 2024 1.81 Mn
Mar 31, 2024 879,000.00
Dec 31, 2023 2.48 Mn
Sep 30, 2023 1.68 Mn
Jun 30, 2023 883,000.00
Dec 31, 2022 2.23 Mn
Mar 31, 2022 450,000.00
Dec 31, 2021 1.47 Mn
Jun 30, 2021 77,000.00
Mar 31, 2021 180,000.00
Dec 31, 2020 1.26 Mn
Sep 30, 2020 79,000.00
Jun 30, 2020 120,000.00